Either Calico or Altos Labs publicly announces a Phase I clinical trial has begun for a therapy aimed at extending human lifespan or healthspan, with the first patient dosed, on or before 2027-06-28.
Resolves Yes if Either Calico or Altos Labs publicly announces a Phase I clinical trial has begun for a therapy aimed at extending human lifespan or healthspan, with the first patient dosed, on or before 2027-06-28.
Outcome verified from calicolabs.com.
Trading on material non-public information is prohibited. Markets are for entertainment and informational purposes using free Pulse Credits — no real-money wagering. If you believe a participant has acted on inside information, please report it.
Analyzing this market…